Financials

News Ideas Discussions Technicals Seasonals

NANEXA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Nanexa AB engages in the development, production, and distribution of medical nanotechnology products. The firm's product, PharmaShell, provides possibilities for drug administration, dosage, and for targeting of parenteral drugs. It also offers Nanexa gas barrier and antifungal coating. The company was founded by Mats Boman, Jan-Otto Carlsson, Christian Östberg, Anders Hårsta, Mårten Rooth, Jessica Östberg, and Anders Johansson in 2007 and is headquartered in Uppsala, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

NANEXA has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company